Follow
Susmita Mandal
Title
Cited by
Cited by
Year
A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells
S Sahoo, A Mishra, H Kaur, K Hari, S Muralidharan, S Mandal, MK Jolly
NAR cancer 3 (3), zcab027, 2021
522021
Immunosuppressive traits of the hybrid epithelial/mesenchymal phenotype
S Sahoo, SP Nayak, K Hari, P Purkait, S Mandal, A Kishore, H Levine, ...
Frontiers in immunology 12, 797261, 2021
512021
Epithelial-to-mesenchymal transition enhances cancer cell sensitivity to cytotoxic effects of cold atmospheric plasmas in breast and bladder cancer systems
P Wang, R Zhou, P Thomas, L Zhao, R Zhou, S Mandal, MK Jolly, ...
Cancers 13 (12), 2889, 2021
362021
Quantifying the patterns of metabolic plasticity and heterogeneity along the epithelial–hybrid–mesenchymal spectrum in cancer
S Muralidharan, S Sahoo, A Saha, S Chandran, SS Majumdar, S Mandal, ...
Biomolecules 12 (2), 297, 2022
162022
Single-cell analysis reveals partial reactivation of X chromosome instead of chromosome-wide dampening in naive human pluripotent stem cells
S Mandal, D Chandel, H Kaur, S Majumdar, M Arava, S Gayen
Stem Cell Reports 14 (5), 745-754, 2020
152020
Investigating epithelial‐mesenchymal heterogeneity of tumors and circulating tumor cells with transcriptomic analysis and biophysical modeling
F Bocci, S Mandal, T Tejaswi, MK Jolly
Computational and Systems Oncology 1 (2), e1015, 2021
132021
Transcriptomic-based quantification of the epithelial-hybrid-mesenchymal spectrum across biological contexts
S Mandal, T Tejaswi, R Janivara, S Srikrishnan, P Thakur, S Sahoo, ...
Biomolecules 12 (1), 29, 2021
122021
PD-L1 activity is associated with partial EMT and metabolic reprogramming in carcinomas
S Muralidharan, M Sehgal, R Soundharya, S Mandal, SS Majumdar, ...
Current Oncology 29 (11), 8285-8301, 2022
102022
In silico analysis of ion channels and their correlation with epithelial to mesenchymal transition in breast cancer
KTS Parthasarathi, S Mandal, S Singh, S Gundimeda, MK Jolly, A Pandey, ...
Cancers 14 (6), 1444, 2022
102022
Semicoordinated allelic-bursting shape dynamic random monoallelic expression in pregastrulation embryos
HC Naik, K Hari, D Chandel, S Mandal, MK Jolly, S Gayen
IScience 24 (9), 2021
72021
Unique sphingolipid signature identifies luminal and triple‐negative breast cancer subtypes
A Kar, N Medatwal, K Rajput, S Mandal, T Pani, A Khan, P Sharma, ...
International Journal of Cancer 152 (11), 2410-2423, 2023
32023
An integrative systems biology approach identifies molecular signatures associated with gallbladder cancer pathogenesis
N Roy, M Kshattry, S Mandal, MK Jolly, DK Bhattacharyya, P Barah
Journal of Clinical Medicine 10 (16), 3520, 2021
32021
Analysis of yes-associated protein-1 (YAP1) target gene signature to predict progressive breast cancer
G Venkatasubramanian, DA Kelkar, S Mandal, MK Jolly, M Kulkarni
Journal of Clinical Medicine 11 (7), 1947, 2022
22022
Transcriptional bursting shape autosomal dynamic random monoallelic expression in pre-gastrulation embryos
CH Naik, D Chandel, S Mandal, S Gayen
bioRxiv, 2020
22020
Identification and characterization of Nattokinase producing bacteria and optimization of enzyme production
D Choubey, K Dhusia, N Gupta, NA Viswan, S Mandal
12016
An Endosomal Acid-Regulatory Feedback System Rewires Cytosolic cAMP Metabolism and Drives Tumor Progression
H Prasad, S Mandal, JKK Mathew, A Cherukunnath, AS Duddu, ...
Molecular Cancer Research, OF1-OF17, 2024
2024
Multi-modal transcriptomic analysis unravels enrichment of hybrid epithelial/mesenchymal state and enhanced phenotypic heterogeneity in basal breast cancer
S Sahoo, S Ramu, MG Nair, M Pillai, BP San Juan, HZ Milioli, S Mandal, ...
bioRxiv, 2023
2023
Aberrations in ion channels interacting with lipid metabolism and epithelial mesenchymal transition in esophageal squamous cell carcinoma
KT Parthasarathi, S Mandal, JP George, KB Gaikwad, S Sasidharan, ...
Frontiers in Molecular Biosciences 10, 1201459, 2023
2023
Integrative systems biology approach identified crucial genes and transcription factors associated with gallbladder cancer pathogenesis
N Roy, M Kshattry, S Mandal, MK Jolly, DK Bhattacharyya, P Barah
bioRxiv, 2021.04. 09.439151, 2021
2021
Exploring the use of ccfDNA analysis and sequencing as diagnostics or prognostics in cancer
A Parchure, M Sharma, S Mandal, S Srinivasan, V Choudhary
FEBS letters, 2007
2007
The system can't perform the operation now. Try again later.
Articles 1–20